Page 1078 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1078

Chapter 70







                   REFERENCES

                    1. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial     14. Samonis G, Gikas A, Anaissie EJ, et al. Prospective evaluation
                      bloodstream infections in US hospitals: analysis of 24,179 cases   of effects of broad-spectrum antibiotics on gastrointestinal
                      from a prospective nationwide surveillance study.  Clin Infect   yeast colonization of humans.  Antimicrob Agents Chemother.
                      Dis. 2004;39:309-317.                                  1993;32:51-53.
                    2. Leon C, Alvarez-Lerma F, Ruiz-Santans S, et al. Fungal coloniza-    15. Mermel LA, Allon M, Bouzo E, et al. Clinical practice guidelines
                      tion and/or infection in non-neutropenic critically ill patients:   for the diagnosis and management of intravascular catheter-
                      results of the EPCAN observational study. Eur J Clin Microbiol   related infection: 2009 update by the Infectious Diseases Society
                      Infect Dis. 2009;28:233-242.                           of America. Clin Infect Dis. 2009;49:1-45.
                    3. Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attrib-    16. Kauffman CA. Candiduria. Clin Infect Dis. 2005;41:S371-S376.
                      utable outcomes of candidemia in adults and children hospital-    17. Barkauskas CE, Perfect JR. Candida pneumonia: what we know
                      ized in the United States: a propensity analysis. Clin Infect Dis.   and what we don’t. Curr Fungal Infect Rpt. 2009;3:21-31.
                      2005;41:1232-1239.
                                                                           18. Pertowski CA, Baron RC, Lasker BA, et al. Nosocomial outbreak
                    4. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology   of Candida albicans sternal wound infections following cardiac
                      of sepsis and infection in ICU patients from an international   surgery traced to a scrub nurse. J Infect Dis. 1995;172:817.
                      multicentre cohort study. Intensive Care Med. 2002;28:108-121.
                                                                           19. Sanchez V, Vazquez JA, Barth-Jones D, et al. Nosocomial acqui-
                    5. Pfaller MA, Diekema DJ. Epidemiology of invasive candi-  sition of Candida parapsilosis: an epidemiological study. Am J
                      diasis: a persistent public health problem. Clin Microbiol Rev.   Med. 1993;94:577-582.
                      2007;20:133-163.
                                                                           20. Malani  PN, McNeil  SA, Bradley SF, Kauffman CA.  Candida
                    6. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National   albicans sternal wound infections: a chronic and recurrent com-
                      epidemiology of mycoses survey (NEMIS): variations in rates of   plication of median sternotomy. Clin Infect Dis. 2002;35:1316.
                      bloodstream infections due to Candida species in seven surgical
                      intensive care units and six neonatal intensive care units. Clin     21. Trofa D, Gacser A, Nosanchuk JD.  Candida parapsilosis,
                      Infect Dis. 1999;29:253-258.                           an  emerging  fungal  pathogen.  Clin Microbiol Rev.  2008;21:
                                                                             606-625.
                    7. Bouza E, Munoz P. Epidemiology of candidemia in intensive
                      care units. Internat J Antimicrob Agents. 2008;32:S87-S91.    22. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for
                                                                             candidal bloodstream infections in surgical intensive care unit
                    8. Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candi-  patients: the NEMIS prospective multicenter study. Clin Infect
                      demia-related hospitalization in the United States, 2000-2005.   Dis. 2001;33:177-186.
                      Infect Control Hosp Epidemiol. 2008;29:978-980.
                                                                           23. Pappas PG, Rex JH, Lee J, et al. A prospective observational
                    9. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida spe-  study of candidemia: epidemiology, therapy, and influences on
                      cies infections in critically ill non-immunosuppressed patients.   mortality in hospitalized adult and pediatric patients. Clin Infect
                      Lancet Infect Dis. 2003;3:685-702.                     Dis. 2003;37:634-643.
                   10. Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergil-    24. Shorr AF, Lazarus DR, Sherner JH, et al. Do clinical features
                      losis in the intensive care unit. Clin Infect Dis. 2007, 45:205-216.  allow for accurate prediction of fungal pathogenesis in blood-
                   11. Khasawneh F, Mohamed T, Moughrabieh MK, et al. Isolation of   stream infections? Potential implications of the increasing
                      Aspergillus in critically ill patients: a potential marker of poor   prevalence of non-albicans candidemia.  Crit Care Med. 2007:
                      outcome. J Crit Care. 2006;21:322-327.                 35:1077-1083.
                   12. Pfaller MA. Nosocomial candidiasis: emerging spe-    25. Diekema DJ, Messer SA, Brueggemann AB, et al. Epidemiology
                      cies,  reservoirs,  and  modes of  transmission.  Clin Infect Dis.   of candidemia: 3-year results from the emerging infections and
                      1996;22:S89-S94.                                       the epidemiology of Iowa organisms study.  J Clin  Microbiol.
                   13. Wright WL, Wenzel RP. Nosocomial  Candida. epidemiol-  2002;40:1298-1302.
                      ogy, transmission, and infection.  Infect Dis Clin North Am.     26. Davis SL, Vazquez JA, McKinnon PS. Epidemiology, risk fac-
                      1997;11:411-425.                                       tors, and outcomes of  Candida albicans versus non-albicans









          Section05-O-ref.indd   1                                                                                   1/20/2015   4:51:22 PM
   1073   1074   1075   1076   1077   1078   1079   1080   1081   1082   1083